Screener
Tvardi Therapeutics TVRD Q1 2026 Annual earnings
Reported May 8, 2026 · Before market open
EPS-$0.73Miss by $0.08
EPS estimate-$0.65
Next report
Date not yet announcedVersus estimates
Diluted EPS
FAQ
- When did Tvardi Therapeutics report Q1 2026 earnings?
- Tvardi Therapeutics (TVRD) reported Q1 2026 earnings on May 8, 2026 before market open.
- What were Tvardi Therapeutics's Q1 2026 revenue and EPS?
- Tvardi Therapeutics reported eps of $-0.73 for Q1 2026.
- Did Tvardi Therapeutics beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-0.65 by $0.08.
- How did Tvardi Therapeutics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 77.3% from $-3.22.
- Where can I find Tvardi Therapeutics's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-057524) and the 10-K periodic report (0001104659-26-037729) directly on SEC EDGAR. The filing index links above go to sec.gov.
